Opinion|Videos|April 4, 2025
Implementation Barriers
Experts discuss the most significant barriers to continuous glucose monitoring (CGM) implementation encountered in their respective roles and how these barriers vary across different patient populations and care settings.
Advertisement
Episodes in this series
Video content above is prompted by the following:
What are the most significant barriers to CGM implementation you've encountered in your respective roles?
How do these barriers vary across different patient populations and care settings?
Newsletter
Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.
Advertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on AJMC
1
Ocrelizumab Leads to Lower Hospitalization Rates Compared to Rituximab in MS
2
Zanubrutinib Shows Similar Efficacy but Better Safety Than VEN–I in Frontline CLL
3
Mirvetuximab Soravtansine Demonstrates Promising Efficacy, Safety in Platinum-Resistant Recurrent Ovarian Cancer
4
The Changing Treatment Landscape of IPF and PPF: Toby Maher, MD, PhD
5
